Navigating the Challenges of Acanthamoeba Keratitis: Current Trends and Future Directions
Life · 10.06.2025 · 15 (6) · 933
DOI: 10.3390/life15060933 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 10.06.2025. Verfasst von Lanxing Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, East Kent Hospitals University NHS Foundation Trust, Canterbury CT1 3NG, UK. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acanthamoeba keratitis (AK) is a vision-threatening eye infection induced by the free-living species of the amoeba genus Acanthamoeba, presenting considerable therapeutic difficulties due to its frequently delayed diagnosis, chronic nature, and resistance to standard treatments. This review examines the changing landscape of AK, emphasizing recent developments in pathogenesis, diagnosis, and treatment. We examine the molecular pathways that enable Acanthamoeba invasion and persistence in the cornea, and how comprehending these processes can inform the creation of more effective treatment therapies. The review emphasizes current advancements in diagnostic methodologies, such as PCR-based tests and in vivo confocal imaging, which have enhanced early detection rates and diagnostic precision. Furthermore, we analyze contemporary treatment modalities, including antimicrobial therapy and surgical procedures, while recognizing the difficulties presented by antimicrobial resistance and the lack of standardized treatment protocols. This review seeks to deliver a thorough examination of AK, presenting insights into cutting-edge treatments and pinpointing essential areas for future research to address the persistent hurdles in controlling this potentially devastating ocular infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, East Kent Hospitals University NHS Foundation Trust, Canterbury CT1 3NG, UK.
- Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
- Department of Ophthalmology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
- Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK.
- Imperial College Ophthalmic Research Group (ICORG) Unit, Imperial College, London NW1 5QH, UK.
- Department of Neurosciences, Reproductive Sciences and Dentistry, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy.
ORCID-Profile: Lanxing Fu, Joanna Wasielica-Poslednik, Gerd Geerling, Fabiana D'Esposito, Mutali Musa, Rosa Giglio, Caterina Gagliano, Marco Zeppieri
Zitieren
APA
Fu, L., Wasielica-Poslednik, J., Geerling, G., Robbie, S., D'Esposito, F., Musa, M., Tognetto, D., Giglio, R., Gagliano, C., & Zeppieri, M. (2025). Navigating the Challenges of Acanthamoeba Keratitis: Current Trends and Future Directions. Life, 15(6), 933. https://doi.org/10.3390/life15060933
Vancouver
Fu L, Wasielica-Poslednik J, Geerling G, Robbie S, D'Esposito F, Musa M, et al. Navigating the Challenges of Acanthamoeba Keratitis: Current Trends and Future Directions. Life. 2025;15(6):933. doi:10.3390/life15060933
BibTeX
@article{Fu2025,
author = {Fu, Lanxing and Wasielica-Poslednik, Joanna and Geerling, Gerd and Robbie, Scott and D'Esposito, Fabiana and Musa, Mutali and Tognetto, Daniele and Giglio, Rosa and Gagliano, Caterina and Zeppieri, Marco},
title = {Navigating the Challenges of Acanthamoeba Keratitis: Current Trends and Future Directions},
journal = {Life},
year = {2025},
volume = {15},
number = {6},
pages = {933},
doi = {10.3390/life15060933}
}
EUVIMED